This website is intended for healthcare professionals only.

Hospital Healthcare Europe
Hospital Pharmacy Europe     Newsletter       

Rheumatology

18
In conversation with consultant rheumatologist Professor Paul Emery
In conversation with consultant rheumatologist Professor Paul Emery
Read more
Rheumatic diseases associated with reproductive issues and adverse pregnancy outcomes, study finds
Rheumatic diseases associated with reproductive issues and adverse pregnancy outcomes, study finds
Read more
Abatacept found to halt the progression of rheumatoid arthritis in high risk patients
Abatacept found to halt the progression of rheumatoid arthritis in high risk patients
Read more
Study shows gout linked to the risk of multiple diseases
Study shows gout linked to the risk of multiple diseases
Read more
MHRA approves bimekizumab for psoriatic arthritis and axial spondyloarthritis
MHRA approves bimekizumab for psoriatic arthritis and axial spondyloarthritis
Read more
Anti-IL17 peptide shows high clinical efficacy for immune-related inflammatory diseases
Anti-IL17 peptide shows high clinical efficacy for immune-related inflammatory diseases
Read more
Do JAK inhibitors increase the risk of MACE in atopic eczema?
Do JAK inhibitors increase the risk of MACE in atopic eczema?
Read more
Psoriatic arthritis risk estimation tool reasonably accurate in psoriasis patients, study finds
Psoriatic arthritis risk estimation tool reasonably accurate in psoriasis patients, study finds
Read more
The evolving management of psoriatic arthritis
The evolving management of psoriatic arthritis
Read more
EULAR develops points to consider for psoriasis to psoriatic arthritis transition
EULAR develops points to consider for psoriasis to psoriatic arthritis transition
Read more
Apremilast benefits in psoriatic arthritis revealed by magnetic resonance imaging
Apremilast benefits in psoriatic arthritis revealed by magnetic resonance imaging
Read more
Use of colchicine associated with reduced risk of hip and knee replacement
Use of colchicine associated with reduced risk of hip and knee replacement
Read more
Long-term opioid use risk in one in three patients with rheumatic and MSK conditions
Long-term opioid use risk in one in three patients with rheumatic and MSK conditions
Read more
Higher malignancy risk with JAK inhibitors in rheumatology compared TNF inhibitors
Higher malignancy risk with JAK inhibitors in rheumatology compared TNF inhibitors
Read more
Two phase 3 trials find bimekizumab effective in both forms of axial spondyloarthritis
Two phase 3 trials find bimekizumab effective in both forms of axial spondyloarthritis
Read more
Osteoarthritis progression identifiable using plasma proteomics signature
Osteoarthritis progression identifiable using plasma proteomics signature
Read more
Study investigates anti-rheumatic drug dose and incident retinopathy
Study investigates anti-rheumatic drug dose and incident retinopathy
Read more
Meet the Expert: Philip Mease on psoriatic arthritis
Meet the Expert: Philip Mease on psoriatic arthritis
Read more

Popular articles

Genetic link between pancreatitis risk and GLP-1 medicines to be investigated
Setting a new standard in blood-borne virus testing and detection in the ED
Further progress in predicting methotrexate response in JIA
Research, consensus and progress in fighting TB: ESCMID Global insights
Significant strain on paediatric workforce poses serious risks to child health, RCPCH warns as it calls for action



 
FOLLOW US

IMPORTANT LINKS

MORE FROM COGORA

© Cogora 2025
Cogora Limited. 1 Giltspur Street, London EC1A 9DD Registered in the United Kingdom. Reg. No. 2147432

Cogora
x